Market Cap
HK$57.54 Billion
HKD as of July 1, 2025
US$7.33 Billion
| Company | Market Cap (USD) |
|---|---|
McKesson Corporation
|
$88.11 B |
Cencora, Inc.
|
$56.44 B |
Cardinal Health, Inc.
|
$38.66 B |
Henry Schein, Inc.
|
$9.31 B |
Shanghai Pharmaceuticals Holding Co. Ltd
|
$8.37 B |
| Company | Market Cap (USD) |
|---|---|
Lilly
|
$699.59 B |
Johnson & Johnson
|
$374.29 B |
AbbVie
|
$336.94 B |
Novo Nordisk
|
$309.91 B |
UnitedHealth Group
|
$279.90 B |
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
China
languages
Healthcare
languages
Medical Distribution
China Healthcare
China Medical Distribution
Sinopharm Group Co. Ltd has the following listings and related stock indices.
Stock: HKEX: 1099
Stock: FSX: X2S
Stock: FSX: X2S1
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.